{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31520895",
  "DateCompleted": {
    "Year": "2020",
    "Month": "03",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "11",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "08",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ahj.2019.08.008",
      "S0002-8703(19)30206-6"
    ],
    "Journal": {
      "ISSN": "1097-6744",
      "JournalIssue": {
        "Volume": "217",
        "PubDate": {
          "Year": "2019",
          "Month": "Nov"
        }
      },
      "Title": "American heart journal",
      "ISOAbbreviation": "Am Heart J"
    },
    "ArticleTitle": "Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise (CardioRACE): Rationale, design, and methods.",
    "Pagination": {
      "StartPage": "101",
      "EndPage": "111",
      "MedlinePgn": "101-111"
    },
    "Abstract": {
      "AbstractText": [
        "The benefits of aerobic exercise (AE) for cardiovascular disease (CVD) have been well documented. Resistance exercise (RE) has been traditionally examined for its effects on bone density, physical function, or metabolic health, yet few data exist regarding the benefits of RE, independent of and combined with AE, for CVD prevention. This randomized controlled trial, \"Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise (CardioRACE),\" is designed to determine the relative benefits of RE, AE, or combined RE plus AE training on CVD risk factors.",
        "Participants are 406 inactive men and women (35-70\u202fyears) with a body mass index of 25-40\u202fkg/m<sup>2</sup> and blood pressure (BP) of 120-139/80-89\u202fmm Hg without taking antihypertensive medications. Participants are randomly assigned to RE only, AE only, combined RE and AE (CE), or a no exercise control group. Participants perform supervised exercise at 50%-80% of their relative maximum intensity for both AE and RE, 3 times a week for 60\u202fminutes per session, for 1\u202fyear (all 3 groups are time matched).",
        "The primary outcome is a composite z score including resting BP, low-density lipoprotein cholesterol (LDL-C), fasting glucose, and percent body fat, which is assessed at baseline, 6 months, and 12 months. Diet and outside physical activity are measured throughout the intervention for 1\u202fyear.",
        "CardioRACE (ClinicalTrials.govNCT03069092) will fill an important knowledge gap regarding the effects of RE, alone or in addition to the well-documented effects of AE. CardioRACE will help generate more comprehensive and synergistic clinical and public health strategies to prevent CVD."
      ],
      "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Kinesiology, Iowa State University, Ames, IA."
          }
        ],
        "LastName": "Brellenthin",
        "ForeName": "Angelique G",
        "Initials": "AG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Food Science and Human Nutrition, Iowa State University, Ames, IA."
          }
        ],
        "LastName": "Lanningham-Foster",
        "ForeName": "Lorraine M",
        "Initials": "LM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Kinesiology, Iowa State University, Ames, IA."
          }
        ],
        "LastName": "Kohut",
        "ForeName": "Marian L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Statistics, University of California-Riverside, Riverside, CA."
          }
        ],
        "LastName": "Li",
        "ForeName": "Yehua",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Preventive Medicine, Pennington Biomedical Research Center, Baton Rouge, LA."
          }
        ],
        "LastName": "Church",
        "ForeName": "Timothy S",
        "Initials": "TS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Exercise Science, University of South Carolina, Columbia, SC."
          }
        ],
        "LastName": "Blair",
        "ForeName": "Steven N",
        "Initials": "SN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Kinesiology, Iowa State University, Ames, IA. Electronic address: dclee@iastate.edu."
          }
        ],
        "LastName": "Lee",
        "ForeName": "Duck-Chul",
        "Initials": "DC"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT03069092"
        ]
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HL133069",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article",
      "Randomized Controlled Trial",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am Heart J",
    "NlmUniqueID": "0370465",
    "ISSNLinking": "0002-8703"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipoproteins, LDL"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Blood Pressure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Mass Index"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Lipoproteins, LDL"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Compliance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Selection"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Resistance Training"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}